期刊文献+

全氟碳纳米粒载体靶向诊断治疗的研究 被引量:3

Research on Perfluorocarbon Nanoparticles Carrier in the Targeted Diagnosis and Treatment
原文传递
导出
摘要 全氟碳纳米粒是近年来出现的一种新型药物载体,它具有很多独特的性能,如化学稳定性好、生物相容性好、携氧能力高、靶向性组织细胞作用等。现综述全氟碳纳米粒的理化性质和应用研究,总结其作为一种靶向载体在心血管系统、神经系统疾病及肿瘤的诊断和治疗方面的研究进展,进一步阐述其可以选择性作用于靶细胞、组织,快速释放药物,从而达到满意的治疗效果,并认为全氟碳纳米粒作为载体靶向诊断治疗具有较好的前景和临床应用价值。 The perfluorocarbon (PFC) nanoparticle is a sort of new drug carrier in recent years, and it has lots of u nique properties such as chemical stability, favourable biocompatibility, high aerobic capacity, targeting action to tis sues or cells and so on. In this paper, we summarize the physieochemical properties of the PFC nanopartieles. We also show the research progress of the PFC nanoparticles as a kind of drug carrier for targeted therapy of cardiovascu lar system, nervous system diseases and tumor. Further more, its characteristics of being selectively in target cells, tissues, and rapid release of drugs are expounded. PFC nanoparticles, as drug carriers for targeted diagnosis and treatment, have good prospect and clinical application value.
出处 《生物医学工程学杂志》 CAS CSCD 北大核心 2012年第6期1217-1220,共4页 Journal of Biomedical Engineering
基金 广东省科技计划资助项目(2010B31600109) 广东省医学科研基金资助项目(2010338)
关键词 全氟碳纳米粒 载体 靶向诊断治疗应用 Perfluorocarbon (PFC) nanoparticle Drug carriers Clinical application of targeted diagnosis and treat-ment
  • 相关文献

参考文献26

二级参考文献98

共引文献65

同被引文献72

  • 1解立新,刘又宁.液体通气的临床应用进展[J].中华结核和呼吸杂志,2007,30(10):730-733. 被引量:5
  • 2van Vlerken LE, Amiji MM.Muhi-functional polymeric nanoparticles for tumour-targeted drug delivery.Expert Opin Drug Deliv, 2006, 3(2) :205-216.
  • 3Hemot S, Klibanov AL.Microbubbles in ultrasound-triggered drug and gene delivery.Adv Drug Deliv Rev, 2008,30(10) : 1153-1166.
  • 4Dtaz-L6pez R,Tsapis N,Fattal E.Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI.Pharm Res, 2010,27( 1 ): 1-16.
  • 5Duncan R, Sat - Klopsch YN, Burger AM, et al. Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate.Cancer Chemother Pharmacol,2013, 72(2) :417-427.
  • 6Crowder KC, Hughes MS, Marsh JN, et al. Sonic activationof molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.Ultrasound Med Biol, 2005,31(12):1693-1700.
  • 7Soman NR, Marsh JN, Hughes MS, et al.Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity.IEEE Trans Nanobioscience, 2006,5 (2) : 69-75.
  • 8Soman NR, Lanza GM, Heuser JM, et al.Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides.Nano Lett, 2008,8(4) : 1131-1136.
  • 9Soman NR, Baldwin SL, Hu G, et al.Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.J Clin Invest, 2009,119(9) : 2830-2842.
  • 10Partlow KC, Lanza GM, Wickline SA.Exploiting lipid raft transport with membrane targeted nanoparticles:A strategy for cytosolic drug delivery.Biomaterials, 2008,29( 23 ) : 3367-3375.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部